Pharmaceutical group’s earnings forecast unchanged


Positive news: The bottling of the Covid-19 vaccine from Sinovac by Pharmaniaga is expected to begin soon.

PETALING JAYA: Pharmaniaga Bhd’s earnings forecast for the financial year 2020 and 2021 remains unchanged, pending further disclosure from the management on the earnings impact resulting from the fill-and-finish agreement, said MIDF Research.

The research house also reiterated its earlier view that the potential upside from the fill-and-finish as well as vaccine distribution will more or less be rather minimal on the company’s earnings.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Business News

Industrial projects look increasingly attractive
Dutch Lady’s balancing act amid escalating costs
Demand for co-working space remains resilient
Fed dampens hopes for rate cut
F&N to use cost management measures
Changing office space requirements
Naza makes entry into green economy
CapBay aims to provide financing to more SMEs
New initiative for infrastructure needs in Perak
Ocean Fresh seeks ACE Market listing

Others Also Read